C-reactive protein levels in obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
C-reactive protein (CRP) levels in obese patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
C-reactive protein (CRP) levels in obstructive sleep apnea (OSA) patients and relation to severity of OSA Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
C-reactive protein (CRP) and prevalence of cardiovascular diseases in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Association of C-reactive protein and unrecognized sleep-related breathing disorders in elderly – the SYNAPSE study Source: Eur Respir J 2007; 30: Suppl. 51, 590s Year: 2007
Association between lipid peroxidation and inflammation in obstructive sleep apnoea Source: Eur Respir J 2006; 28: 378-385 Year: 2006
High sensitivity C-reactive protein (CRP) in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 566s Year: 2003
Interleukin-6 and C-reactive protein serum levels in children with obstructive sleep-disordered breathing Source: Annual Congress 2008 - Sleep apnoea in childhood Year: 2008
Interaction between body weight obstructive sleep apnea (OSA) on C-reactive protein (CRP) in an otherwise healthy population: The EPIOSA study Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015
Elevated c-reactive protein (CRP) levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
Elevated c-reactive protein in patients with obstructive sleep apnea hypopnea syndrome (OSAH) Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
C-reactive protein levels can predict obstructive sleep apnea / hypopnea syndrome? Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004
Long term effect of APAP on C-reactive protein and IL-6 in obstructive sleep apnoea patients Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008
Plasma levels of vascular endothelial growth factor in children with sleep-disordered breathing Source: Annual Congress 2005 - Sleep apnoea in children Year: 2005
Increased troponin T levels in haemodialysis patients are not associated with sleep related breathing disorders Source: Annual Congress 2005 - What should we know about our SAS patients Year: 2005
Cardiovascular diseases are responsible for increased plasma NT-proBNP level in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Clock gene dysfunction in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2008; 32: 105-112 Year: 2008
Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010